To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene C20orf4TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
297 supporting clones for gene C20orf4 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
CR590998 HeLa cells Cot 25-normalized .a 1 to 1466 1 to 1466 exact tiling clone,   1466/1466
(100 %)
0 diff
(100 %id)
BX384632   .a 1 to 897 1 to 895   fully sequenced,   895/895
(100 %)
3 diff
(99.7 %id)
TI_57201214   .a 6 to 838 48 to 881       834/887
(94 %)
11 diff
(98.8 %id)
DB458374 testis .a 9 to 485 1 to 477       477/477
(100 %)
0 diff
(100 %id)
BI666523 brain, hypothalamus .a 9 to 820 1 to 814       814/896
(90 %)
15 diff
(98.4 %id)
DB485104 hypothalamus .a 14 to 460 1 to 448       448/448
(100 %)
3 diff
(99.4 %id)
DB491362 hypothalamus .a 14 to 407 1 to 393       393/393
(100 %)
11 diff
(97.3 %id)
DB495382 hypothalamus .a 14 to 519 1 to 507       507/507
(100 %)
5 diff
(99.1 %id)
DB495710 hypothalamus .a 14 to 518 1 to 505       505/505
(100 %)
1 diff
(99.9 %id)
TI_57175323   .a 14 to 894 20 to 896       877/897
(97 %)
11 diff
(98.8 %id)
TI_44342714   .a 14 to 820 129 to 937       809/1019
(79 %)
18 diff
(98.3 %id)
CN306565 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 18 to 335 1 to 318       318/318
(100 %)
0 diff
(100 %id)
CN306567 embryonic stem cells, cell lines H1, H7, andH9 .a 18 to 677 1 to 658       658/658
(100 %)
4 diff
(99.4 %id)
BG437444 large cell carcinoma, lung .a 19 to 854 1 to 837       837/915
(91 %)
21 diff
(97.8 %id)
BI223387 cervical carcinoma cell line, cervix .a 23 to 772 1 to 749       749/749
(100 %)
3 diff
(99.6 %id)
CX865393 embryonic stem .a 23 to 884 1 to 862       862/862
(100 %)
5 diff
(99.5 %id)
BG394352 eye, retinoblastoma .a 26 to 752 1 to 719       719/981
(73 %)
17 diff
(98.3 %id)
BG818091 anaplastic oligodendroglioma with 1p/19qloss, brain .a 26 to 809 1 to 785       785/785
(100 %)
6 diff
(99.3 %id)
BI828623 brain, medulla .a 26 to 894 1 to 866       866/867
(99 %)
5 diff
(99.5 %id)
BF308459 muscle, rhabdomyosarcoma .a 27 to 748 1 to 711       711/716
(99 %)
20 diff
(97.3 %id)
BG119469 adenocarcinoma, cell line, Liver .a 27 to 715 1 to 684       684/953
(71 %)
10 diff
(99.0 %id)
BI823959 pooled brain, lung, testis .a 27 to 838 1 to 813       813/819
(99 %)
5 diff
(99.4 %id)
BI766728 pooled lung and spleen .a 27 to 804 8 to 787       780/787
(99 %)
26 diff
(96.7 %id)
TI_57180783   .a 27 to 804 32 to 811       780/811
(96 %)
26 diff
(96.8 %id)
BI333307 cervical carcinoma cell line, cervix .a 28 to 95 1 to 68       68/68
(100 %)
0 diff
(100 %id)
TI_57215267   .a 28 to 772 66 to 810       745/810
(91 %)
6 diff
(99.3 %id)
BM472636 embryonal carcinoma, cell line, testis .a 29 to 838 1 to 811       811/917
(88 %)
14 diff
(98.5 %id)
BG281950 melanotic melanoma, skin .a 32 to 933 1 to 902       902/905
(99 %)
13 diff
(98.6 %id)
BI752243 brain .a 32 to 772 1 to 741       741/741
(100 %)
0 diff
(100 %id)
BI906042 leukocyte .a 32 to 909 1 to 881       881/1095
(80 %)
17 diff
(98.5 %id)
BG821466 adenocarcinoma cell line, colon .a 35 to 591 2 to 558       557/558
(99 %)
0 diff
(100 %id)
BG422851 Kidney, renal cell adenocarcinoma .a 42 to 666 1 to 625       625/625
(100 %)
0 diff
(100 %id)
BG749950 eye, normal pigmented retinal epithelium .a 42 to 810 1 to 778       778/975
(79 %)
23 diff
(97.7 %id)
BU151561 eye, normal pigmented retinal epithelium .a 44 to 851 1 to 811       811/946
(85 %)
11 diff
(98.9 %id)
BF529810 anaplastic oligodendroglioma with 1p/19qloss, brain .a 45 to 836 12 to 805       794/842
(94 %)
44 diff
(94.8 %id)
BG281908 melanotic melanoma, skin .a 45 to 854 14 to 819       806/886
(90 %)
31 diff
(96.6 %id)
BG489465 large cell carcinoma, lung .a 45 to 553 9 to 532       524/834
(62 %)
6 diff
(99.3 %id)
BG475868 melanotic melanoma, skin .a 45 to 787 15 to 761       747/762
(98 %)
7 diff
(99.1 %id)
BG477271 melanotic melanoma, skin .a 45 to 810 15 to 783       769/840
(91 %)
36 diff
(95.8 %id)
BI855917 breast, mammary adenocarcinoma, cell line .a 45 to 837 27 to 825       799/826
(96 %)
16 diff
(98.1 %id)
BQ060128 lymph, lymphoma, cell line .a 45 to 838 38 to 840       803/1048
(76 %)
24 diff
(97.8 %id)
BQ947820 large cell carcinoma, lung .a 45 to 854 7 to 818       812/973
(83 %)
12 diff
(98.8 %id)
TI_57186207   .a 45 to 837 82 to 880       799/826
(96 %)
16 diff
(98.1 %id)
DN995327 breast cancer, Mammary gland (cancer tissue) .a 45 to 596 9 to 559       551/559
(98 %)
6 diff
(99.0 %id)
BX447071 neuroblastoma .a 46 to 827 1 to 784       784/788
(99 %)
10 diff
(98.8 %id)
BE295890 muscle, rhabdomyosarcoma .a 46 to 468 1 to 422       422/422
(100 %)
2 diff
(99.6 %id)
BE269875 Burkitt lymphoma, lymph .a 46 to 522 1 to 477       477/478
(99 %)
1 diff
(99.8 %id)
BG256536 embryonal carcinoma, cell line, testis .a 46 to 816 1 to 765       765/930
(82 %)
29 diff
(96.9 %id)
BG387205 adenocarcinoma cell line, colon .a 46 to 801 1 to 754       754/983
(76 %)
10 diff
(99.0 %id)
BE728106 melanotic melanoma, skin .a 51 to 836 1 to 775       775/1001
(77 %)
24 diff
(97.7 %id)
BE385397 melanotic melanoma, skin .a 52 to 760 1 to 706       706/708
(99 %)
9 diff
(98.8 %id)
BU189776 leiomyosarcoma, uterus .a 53 to 856 18 to 827       810/879
(92 %)
17 diff
(98.1 %id)
BU196699 melanotic melanoma, cell line, skin .a 53 to 817 4 to 783       780/886
(88 %)
6 diff
(99.4 %id)
BG831947 epithelioid carcinoma cell line, Pancreas .a 54 to 619 1 to 582       582/709
(82 %)
20 diff
(97.2 %id)
BE894676 melanotic melanoma, skin .a 59 to 699 1 to 641       641/641
(100 %)
2 diff
(99.7 %id)
AA587855 adrenal adenoma, adrenal gland .a 74 to 575 1 to 501     Submitted on the opposite strand 501/501
(100 %)
3 diff
(99.5 %id)
CD358205 testis .a 80 to 702 1 to 631       631/921
(68 %)
17 diff
(98.2 %id)
BE514783 adenocarcinoma cell line, ovary .a 86 to 776 1 to 688       688/720
(95 %)
17 diff
(97.7 %id)
CV025895 mixed .a 94 to 675 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BE895445 melanotic melanoma, skin .a 139 to 815 1 to 685       685/686
(99 %)
18 diff
(97.4 %id)
BG419090 Kidney, renal cell adenocarcinoma .a 146 to 854 1 to 705       705/909
(77 %)
11 diff
(98.8 %id)
CF146897 CNCAP(3)T-225 cell line, Prostate .a 176 to 755 8 to 587       580/587
(98 %)
6 diff
(99.0 %id)
CF147340 CNCAP(3)T-225 cell line, Prostate .a 176 to 720 8 to 552       545/552
(98 %)
6 diff
(99.0 %id)
BG025536 lymph, lymphoma, cell line .a 379 to 759 382 to 788       623/968
(64 %)
17 diff
(98.3 %id)
C04355 heart .a 453 to 665 1 to 214       214/214
(100 %)
8 diff
(96.3 %id)
BX384631   .a 867 to 1466 602 to 1   fully sequenced,   602/602
(100 %)
2 diff
(99.7 %id)
FN070844 breast carcinoma .a 968 to 1041 1 to 75       75/75
(100 %)
1 diff
(98.7 %id)
AL527103 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .b 1 to 762 15 to 772   tiling clone,   758/889
(85 %)
14 diff
(98.5 %id)
CX763328 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 31 to 772 1 to 741   tiling clone, Submitted on the opposite strand 741/743
(99 %)
8 diff
(99.0 %id)
AL562840 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .b 1468 to 2486 1017 to 4   tiling clone,   1014/1072
(94 %)
0 diff
(100 %id)
AL545669 placenta, Placenta Cot 25-normalized .c 1 to 1114 19 to 1135       1117/1135
(98 %)
16 diff
(98.6 %id)
CD556963 brain, Pituitary .c 8 to 730 1 to 736   tiling clone,   736/993
(74 %)
37 diff
(96.3 %id)
CD518900 White Matter .c 8 to 828 1 to 828       828/886
(93 %)
21 diff
(97.7 %id)
TI_57202109   .c 18 to 961 29 to 981       953/1150
(82 %)
31 diff
(97.4 %id)
BI822912 pooled brain, lung, testis .c 23 to 961 1 to 948       948/1117
(84 %)
27 diff
(97.6 %id)
BG281987 melanotic melanoma, skin .c 47 to 774 1 to 725       725/725
(100 %)
4 diff
(99.5 %id)
BC019311 Skin, melanotic melanoma. .c 48 to 2695 1 to 2648 exact tiling clone, available from MGC, AAA   2648/2648
(100 %)
1 diff
(100.0 %id)
NM_015511.3   .c 48 to 2695 1 to 2648 exact RefSeq, AAA   2648/2648
(100 %)
1 diff
(100.0 %id)
BE302472 melanotic melanoma, skin .c 49 to 581 1 to 532       532/532
(100 %)
1 diff
(99.9 %id)
BM554390 amelanotic melanoma, cell line, skin .c 1708 to 2694 1045 to 54   AAA Submitted on the opposite strand 992/1091
(90 %)
27 diff
(97.6 %id)
BX342385   .c 1718 to 2654 931 to 5       927/931
(99 %)
0 diff
(100 %id)
BG115820 duodenal adenocarcinoma, cell line, small intestine .c 1721 to 2424 1 to 703       703/1283
(54 %)
26 diff
(98.0 %id)
BE383184 brain, neuroblastoma .c 1753 to 2371 1 to 619       619/619
(100 %)
0 diff
(100 %id)
AA040354 uterus .c 1766 to 1978 1 to 213       213/213
(100 %)
0 diff
(100 %id)
AA150641 uterus .c 1793 to 2184 1 to 394   fully sequenced,   394/394
(100 %)
8 diff
(98.0 %id)
BE390859 endometrium, adenocarcinoma cell line, uterus .c 1807 to 2501 1 to 691       691/708
(97 %)
12 diff
(98.4 %id)
BM916435 amelanotic melanoma, cell line, skin .c 1808 to 2694 960 to 53   AAA Submitted on the opposite strand 908/1113
(81 %)
54 diff
(95.2 %id)
BQ072169 brain, neuroblastoma, cell line .c 1833 to 2693 912 to 39   AAA Submitted on the opposite strand 874/953
(91 %)
27 diff
(97.2 %id)
BM557214 amelanotic melanoma, cell line, skin .c 1854 to 2694 906 to 54   AAA Submitted on the opposite strand 853/1017
(83 %)
21 diff
(98.0 %id)
TI_149273921   .c 1888 to 2694 895 to 88   AAA   808/900
(89 %)
26 diff
(97.2 %id)
BM911580 amelanotic melanoma, cell line, skin .c 1891 to 2694 877 to 52   AAA Submitted on the opposite strand 826/1102
(74 %)
53 diff
(95.2 %id)
BM558887 amelanotic melanoma, cell line, skin .c 1892 to 2694 866 to 54   AAA Submitted on the opposite strand 813/939
(86 %)
32 diff
(96.6 %id)
TI_149314123   .c 1895 to 2694 899 to 106   AAA   794/959
(82 %)
14 diff
(98.6 %id)
TI_149313515   .c 1929 to 2694 871 to 109   AAA   763/928
(82 %)
10 diff
(99.0 %id)
CB305337 lung, Primary Lung Cystic Fibrosis EpithelialCells .c 2001 to 2694 708 to 15   AAA   694/694
(100 %)
2 diff
(99.8 %id)
TI_151717789   .c 2008 to 2696 809 to 122       688/809
(85 %)
0 diff
(100 %id)
AW630546 2 pooled high-grade transitional celltumors, genitourinary tract .c 2013 to 2407 1 to 399       399/399
(100 %)
12 diff
(97.0 %id)
BG491920 amelanotic melanoma, cell line, skin .c 2034 to 2640 610 to 5       606/610
(99 %)
0 diff
(100 %id)
EL950595 eyeball .c 2050 to 2685 1 to 634       634/634
(100 %)
7 diff
(98.9 %id)
BU733884 eye, Retina Foveal and Macular .c 2064 to 2694 647 to 19   AAA   629/629
(100 %)
3 diff
(99.6 %id)
BQ015325 Chondrosarcoma, Left Pubic Bone .c 2070 to 2692 639 to 17   AAA   623/623
(100 %)
0 diff
(100 %id)
AA465568 germinal center B cell .c 2123 to 2418 1 to 296   fully sequenced,   296/296
(100 %)
1 diff
(99.7 %id)
AI300103 2 pooled tumors (clear cell type), Kidney .c 2144 to 2694 563 to 13   AAA   551/551
(100 %)
1 diff
(99.9 %id)
AI743822 pooled .c 2144 to 2694 563 to 12   AAA   552/552
(100 %)
1 diff
(99.9 %id)
BM968328 lung, Primary Lung Epithelial Cells .c 2145 to 2694 568 to 17   AAA   552/552
(100 %)
2 diff
(99.7 %id)
AA142941 uterus .c 2154 to 2696 540 to 1   fully sequenced,   540/540
(100 %)
4 diff
(99.3 %id)
AA640562 alveolar rhabdomyosarcoma .c 2180 to 2606 49 to 475       427/475
(89 %)
6 diff
(98.8 %id)
AA190687   .c 2181 to 2564 1 to 382       382/382
(100 %)
2 diff
(99.5 %id)
BE223089 brain, oligodendroglioma .c 2182 to 2694 513 to 1       513/513
(100 %)
0 diff
(100 %id)
AI057113   .c 2187 to 2694 524 to 17   AAA   508/514
(98 %)
0 diff
(100 %id)
BG819879 anaplastic oligodendroglioma with 1p/19qloss, brain .c 2188 to 2694 1 to 508   AAA   508/508
(100 %)
1 diff
(99.9 %id)
BP394518 pancreatic islet .c 2199 to 2696 1 to 498     Submitted on the opposite strand 498/502
(99 %)
1 diff
(99.9 %id)
BP395391 pancreatic islet .c 2201 to 2696 1 to 497     Submitted on the opposite strand 497/500
(99 %)
2 diff
(99.6 %id)
BE729070 melanotic melanoma, skin .c 2201 to 2694 1 to 493   AAA   493/493
(100 %)
1 diff
(99.8 %id)
AW300985 colon, moderately differentiated adenocarcinoma .c 2217 to 2696 480 to 1       480/480
(100 %)
1 diff
(99.8 %id)
CN306568 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 2219 to 2693 1 to 475       475/475
(100 %)
0 diff
(100 %id)
AA040355 uterus .c 2256 to 2696 443 to 1       443/446
(99 %)
3 diff
(99.4 %id)
BE207389 melanotic melanoma, skin .c 2306 to 2694 409 to 21   AAA   389/389
(100 %)
2 diff
(99.5 %id)
AL545638 placenta, Placenta Cot 25-normalized .c 2338 to 2637 347 to 24       1074/1199
(89 %)
21 diff
(98.3 %id)
AA465214 germinal center B cell .c 2388 to 2703 319 to 4   fully sequenced,   316/319
(99 %)
5 diff
(98.5 %id)
TI_151771649   .c 2521 to 2608 643 to 728       599/1012
(59 %)
45 diff
(95.6 %id)
AW627510 2 pooled high-grade transitional celltumors, genitourinary tract .c 2549 to 2696 153 to 6       148/153
(96 %)
0 diff
(100 %id)
BX387576 Neuroblastoma Cot 25-normalized .d 1 to 893 4 to 893   tiling clone,   890/893
(99 %)
10 diff
(98.9 %id)
AL539135 brain, fetal brain .d 12 to 988 12 to 971       960/1003
(95 %)
28 diff
(97.3 %id)
AL538093 brain, fetal brain .d 13 to 963 1 to 940       940/940
(100 %)
24 diff
(97.5 %id)
BX383785   .d 13 to 908 1 to 894       894/894
(100 %)
2 diff
(99.8 %id)
AL117419 brain .d 15 to 2430 1 to 2415 F45L E146K L240H available from DKFZ, AAA   2415/2415
(100 %)
10 diff
(99.6 %id)
BC001751 Lung, small cell carcinoma .d 28 to 2430 1 to 2403 exact tiling clone, available from MGC, AAA   2403/2403
(100 %)
0 diff
(100 %id)
BF688444 eye, normal pigmented retinal epithelium .d 38 to 804 1 to 760       760/1165
(65 %)
43 diff
(96.4 %id)
AF132957   .d 41 to 1479 7 to 1454 E70K S92N N241I N279H I299M     1448/1455
(99 %)
19 diff
(98.7 %id)
AA070147   .d 41 to 411 7 to 383       377/385
(97 %)
12 diff
(96.9 %id)
AL522042 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .d 42 to 926 1 to 884       884/884
(100 %)
3 diff
(99.7 %id)
BX375425 Neuroblastoma Cot 25-normalized .d 42 to 998 1 to 950       950/956
(99 %)
15 diff
(98.5 %id)
BX375577 Neuroblastoma Cot 25-normalized .d 42 to 1013 1 to 964       964/964
(100 %)
13 diff
(98.7 %id)
BX354464 Neuroblastoma Cot 25-normalized .d 42 to 890 1 to 848       848/848
(100 %)
3 diff
(99.7 %id)
AL527240 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .d 42 to 897 1 to 853       853/853
(100 %)
25 diff
(97.1 %id)
BX358635 Placenta Cot 25-normalized .d 42 to 1078 1 to 1030       1030/1030
(100 %)
11 diff
(99.0 %id)
BX399153 Placenta Cot 25-normalized .d 42 to 988 1 to 941       941/941
(100 %)
9 diff
(99.1 %id)
AL558690 T cells from T cell leukemia .d 42 to 1058 1 to 999       999/1001
(99 %)
25 diff
(97.6 %id)
BM720247 eye, fetal eye .d 43 to 422 12 to 388       377/388
(97 %)
6 diff
(98.5 %id)
TI_1948093272   .d 83 to 654 124 to 694   fully sequenced,   571/694
(82 %)
5 diff
(99.3 %id)
TI_1948092955   .d 89 to 847 126 to 885       760/1431
(53 %)
2 diff
(99.9 %id)
TI_1948093107   .d 89 to 850 129 to 891       763/1394
(54 %)
3 diff
(99.8 %id)
TI_1948093418   .d 89 to 847 128 to 884       757/1403
(53 %)
8 diff
(99.5 %id)
CB594583 Blood, promyelocytic leukemia .d 322 to 1204 1 to 899       897/901
(99 %)
22 diff
(97.6 %id)
BX458437 placenta .d 369 to 1291 1 to 923       923/923
(100 %)
2 diff
(99.8 %id)
CD519414 White Matter .d 387 to 1222 1 to 839       839/841
(99 %)
11 diff
(98.7 %id)
BG761917 melanotic melanoma, high MDR (cell line), skin .d 548 to 1163 115 to 736       704/736
(95 %)
28 diff
(96.2 %id)
BI769017 pooled lung and spleen .d 577 to 1374 1 to 796       796/796
(100 %)
2 diff
(99.8 %id)
TI_57181840   .d 577 to 1374 31 to 826       796/826
(96 %)
8 diff
(99.1 %id)
CN306566 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 602 to 1271 1 to 670       670/670
(100 %)
0 diff
(100 %id)
TI_1948093273   .d 624 to 1243 754 to 121   fully sequenced,   634/754
(84 %)
2 diff
(99.8 %id)
BU956839 adenocarcinoma, cell line, breast .d 646 to 1444 1 to 810       810/876
(92 %)
17 diff
(98.1 %id)
BE614970 adenocarcinoma, Pancreas .d 653 to 1473 1 to 819       819/1043
(78 %)
24 diff
(97.7 %id)
CR594170 HeLa cells Cot 25-normalized .d 662 to 2395 1 to 1734       1734/1734
(100 %)
0 diff
(100 %id)
BX342386   .d 662 to 1610 1 to 947       947/952
(99 %)
12 diff
(98.8 %id)
CD627045   .d 665 to 1365 711 to 12       700/717
(97 %)
1 diff
(99.9 %id)
CD627044   .d 682 to 1263 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
BG746761 adenocarcinoma cell line, colon .d 696 to 1413 1 to 718       718/719
(99 %)
1 diff
(99.9 %id)
AF113672 Liver .d 771 to 2430 1 to 1660   AAA   1660/1660
(100 %)
0 diff
(100 %id)
AI110781 Liver .d 771 to 1491 1 to 718       718/718
(100 %)
3 diff
(99.6 %id)
AF074688 Liver .d 771 to 1491 1 to 718       718/718
(100 %)
3 diff
(99.6 %id)
BM698647 eye, fetal eyes .d 804 to 1158 1 to 355       355/355
(100 %)
0 diff
(100 %id)
BE835543 prostate_normal .d 831 to 1326 504 to 9       496/504
(98 %)
0 diff
(100 %id)
TI_1948092956   .d 846 to 1243 508 to 111       398/1397
(28 %)
3 diff
(99.8 %id)
TI_1948093108   .d 846 to 1243 525 to 128       398/1350
(29 %)
0 diff
(100 %id)
TI_1948093419   .d 846 to 1243 531 to 134       398/1449
(27 %)
1 diff
(100.0 %id)
BU933811 mixed (pool of 40 RNAs) .d 847 to 1404 1 to 566       566/854
(66 %)
22 diff
(97.5 %id)
BM917295 blood, natural killer cells, cell line .d 854 to 1744 1 to 898       898/1056
(85 %)
27 diff
(97.5 %id)
F11478 brain, total brain .d 862 to 1199 1 to 338       338/338
(100 %)
1 diff
(99.8 %id)
F11481 brain, total brain .d 862 to 1201 1 to 340       340/340
(100 %)
3 diff
(99.2 %id)
CF141363 CNCAP(3)T-225 cell line, Prostate .d 876 to 1330 1 to 455       455/455
(100 %)
6 diff
(98.7 %id)
BG057352 blood, lymphocyte .d 879 to 1413 535 to 1       535/535
(100 %)
4 diff
(99.3 %id)
TI_154172086   .d 881 to 1480 76 to 676       601/602
(99 %)
12 diff
(98.1 %id)
W40143 lung .d 941 to 1363 12 to 438       427/444
(96 %)
11 diff
(97.6 %id)
AW327271 blood, T cell leukemia .d 996 to 1643 1 to 656       656/656
(100 %)
12 diff
(98.2 %id)
H14695 whole brain .d 1001 to 1478 1 to 487       487/489
(99 %)
11 diff
(97.8 %id)
BG749651 eye, normal pigmented retinal epithelium .d 1042 to 1768 1 to 733       733/843
(86 %)
14 diff
(98.4 %id)
BG749216 eye, normal pigmented retinal epithelium .d 1042 to 1828 1 to 799       799/1118
(71 %)
37 diff
(96.7 %id)
BF057057 pooled germ cell tumors .d 1051 to 1188 138 to 1       138/138
(100 %)
2 diff
(98.6 %id)
AI657027 pooled germ cell tumors .d 1054 to 1424 389 to 19   AAA   371/373
(99 %)
3 diff
(99.2 %id)
BM916675 amelanotic melanoma, cell line, skin .d 1113 to 1787 1 to 685       685/1240
(55 %)
11 diff
(99.2 %id)
AA314641 colon .d 1127 to 1487 1 to 362       362/362
(100 %)
3 diff
(99.2 %id)
AW954856   .d 1128 to 1763 1 to 636       636/637
(99 %)
5 diff
(99.3 %id)
BU186605 large cell carcinoma, lung .d 1130 to 1993 1 to 873       873/874
(99 %)
16 diff
(98.2 %id)
BM824504 Ascites, stomach .d 1139 to 1612 1 to 474       474/474
(100 %)
0 diff
(100 %id)
CR610727 Neuroblastoma Cot 25-normalized .d 1152 to 2407 1 to 1256       1256/1256
(100 %)
0 diff
(100 %id)
BX394390 Neuroblastoma Cot 25-normalized .d 1152 to 1761 1 to 604   fully sequenced,   604/604
(100 %)
1 diff
(99.9 %id)
BU500955 eye, normal pigmented retinal epithelium .d 1172 to 1803 1 to 644       644/998
(64 %)
24 diff
(97.6 %id)
BE279032 choriocarcinoma, placenta .d 1188 to 1809 1 to 620       620/620
(100 %)
2 diff
(99.7 %id)
BX349168   .d 1241 to 2172 1 to 942       942/984
(95 %)
43 diff
(95.7 %id)
BX358634 Placenta Cot 25-normalized .d 1327 to 2401 1061 to 1       1061/1108
(95 %)
14 diff
(98.8 %id)
AL539134 brain, fetal brain .d 1338 to 2395 1048 to 1       1048/1106
(94 %)
11 diff
(99.1 %id)
AA313457 colon .d 1342 to 1686 1 to 345       345/345
(100 %)
0 diff
(100 %id)
AW961181   .d 1343 to 2019 1 to 678       678/678
(100 %)
17 diff
(97.5 %id)
BE897076 melanotic melanoma, skin .d 1353 to 2137 1 to 784       784/788
(99 %)
18 diff
(97.8 %id)
FN086032 breast carcinoma .d 1359 to 1462 1 to 105       105/105
(100 %)
1 diff
(99.1 %id)
BX375424 Neuroblastoma Cot 25-normalized .d 1363 to 1838 991 to 525       467/1064
(43 %)
0 diff
(100 %id)
BX446398 placenta .d 1367 to 2388 1 to 1010   AAA   1010/1038
(97 %)
26 diff
(97.5 %id)
AL580458 T cells from T cell leukemia .d 1368 to 2370 1027 to 31       997/1030
(96 %)
0 diff
(100 %id)
BI093682 cervix .d 1378 to 2091 1 to 728       728/895
(81 %)
41 diff
(95.5 %id)
CB115898 Liver .d 1389 to 1822 8 to 441       434/441
(98 %)
6 diff
(98.7 %id)
BG171327 hypernephroma, cell line, Kidney .d 1390 to 2091 1 to 704       704/949
(74 %)
39 diff
(95.9 %id)
CB115897 Liver .d 1392 to 1788 11 to 407       397/407
(97 %)
6 diff
(98.6 %id)
BX375576 Neuroblastoma Cot 25-normalized .d 1394 to 2401 1008 to 1       1008/1018
(99 %)
12 diff
(98.9 %id)
BX399152 Placenta Cot 25-normalized .d 1399 to 2402 1004 to 1       1004/1005
(99 %)
7 diff
(99.4 %id)
AL567135 brain, fetal brain .d 1427 to 2409 977 to 1       977/1022
(95 %)
13 diff
(98.8 %id)
H59489 liver and spleen .d 1428 to 1752 1 to 326       326/326
(100 %)
1 diff
(99.7 %id)
BX458436 placenta .d 1433 to 2370 979 to 43       937/979
(95 %)
0 diff
(100 %id)
T63709 lung .d 1437 to 1713 1 to 276       276/276
(100 %)
5 diff
(98.2 %id)
AL562857 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .d 1448 to 2402 954 to 1       954/958
(99 %)
24 diff
(97.5 %id)
BX366536 Neuroblastoma Cot 25-normalized .d 1464 to 2401 939 to 1       939/939
(100 %)
6 diff
(99.4 %id)
BX354463 Neuroblastoma Cot 25-normalized .d 1481 to 2373 895 to 1       895/895
(100 %)
9 diff
(99.0 %id)
AL562053 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .d 1492 to 2403 911 to 1       911/911
(100 %)
15 diff
(98.4 %id)
AA155878.
matches multiple genes
colon, tumor .d 1510 to 1928 1 to 422     also hits gene RBM10 422/430
(98 %)
5 diff
(98.9 %id)
W05136 lung .d 1515 to 1752 1 to 238       238/238
(100 %)
0 diff
(100 %id)
T87444.
matches multiple genes
liver and spleen .d 1537 to 1923 8 to 396     also hits gene ADH6 389/401
(97 %)
11 diff
(97.3 %id)
AW601349 breast .d 1539 to 1763 30 to 254       225/254
(88 %)
6 diff
(97.7 %id)
T92102 liver and spleen .d 1545 to 1868 1 to 329       329/348
(94 %)
12 diff
(96.6 %id)
BF689251 eye, normal pigmented retinal epithelium .d 1576 to 2365 801 to 14       788/1001
(78 %)
0 diff
(100 %id)
BF934515 nervous_tumor .d 1594 to 1847 1 to 255       255/255
(100 %)
2 diff
(99.3 %id)
BG978507 colon_normal .d 1620 to 1939 28 to 352       325/356
(91 %)
6 diff
(98.4 %id)
FN112472 breast carcinoma .d 1664 to 1770 103 to 1     Submitted on the opposite strand 103/103
(100 %)
5 diff
(95.2 %id)
BX394389 Neuroblastoma Cot 25-normalized .d 1731 to 2407 671 to 1   fully sequenced,   671/671
(100 %)
0 diff
(100 %id)
BM671999 eye, fetal eye .d 1739 to 2430 709 to 17   AAA   693/693
(100 %)
1 diff
(99.9 %id)
N84311   .d 1758 to 1972 1 to 215       215/232
(92 %)
6 diff
(97.5 %id)
AI027514 parathyroid gland, parathyroid tumor .d 1965 to 2430 477 to 12   AAA   466/466
(100 %)
3 diff
(99.4 %id)
DB566765 hypothalamus .d 1972 to 2430 1 to 459     Submitted on the opposite strand 459/459
(100 %)
1 diff
(99.8 %id)
DB523871 testis .d 1978 to 2430 1 to 453     Submitted on the opposite strand 453/453
(100 %)
0 diff
(100 %id)
DB566437 hypothalamus .d 1978 to 2430 1 to 453     Submitted on the opposite strand 453/453
(100 %)
3 diff
(99.4 %id)
BU536499 mixed (pool of 40 RNAs) .d 1978 to 2433 1 to 456       456/939
(48 %)
7 diff
(99.3 %id)
FN111806 breast carcinoma .d 1979 to 2066 87 to 1     Submitted on the opposite strand 87/107
(81 %)
1 diff
(99.1 %id)
AA604627 adrenal adenoma, adrenal gland .d 1982 to 2431 450 to 1       450/450
(100 %)
3 diff
(99.4 %id)
AA653558   .d 1982 to 2431 450 to 1       450/450
(100 %)
0 diff
(100 %id)
AA830476 germinal center B cell .d 1982 to 2430 460 to 13   AAA   448/448
(100 %)
1 diff
(99.8 %id)
BF000372 colon, colon tumor, RER+ .d 1985 to 2433 451 to 3       449/451
(99 %)
0 diff
(100 %id)
BI964250 Islets of Langerhans, Pancreas .d 1987 to 2430 1 to 444       444/448
(99 %)
5 diff
(98.9 %id)
CK903875 Islets of Langerhans, Pancreas .d 1987 to 2432 1 to 446       446/447
(99 %)
1 diff
(99.8 %id)
AW006181 anaplastic oligodendroglioma, brain .d 1989 to 2440 452 to 1       452/452
(100 %)
1 diff
(99.8 %id)
AI682980 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .d 1990 to 2431 442 to 1       442/442
(100 %)
0 diff
(100 %id)
DB556536 hypothalamus .d 2000 to 2430 1 to 432     Submitted on the opposite strand 432/432
(100 %)
3 diff
(99.4 %id)
AI360105 anaplastic oligodendroglioma, brain .d 2003 to 2430 440 to 13   AAA   428/428
(100 %)
0 diff
(100 %id)
BM052882 Islets of Langerhans, Pancreas .d 2003 to 2430 1 to 428       428/428
(100 %)
0 diff
(100 %id)
AA676933 liver and spleen .d 2004 to 2430 427 to 1       427/427
(100 %)
1 diff
(99.8 %id)
CA313305 Human Lung Epithelial cells, lung .d 2004 to 2430 443 to 17   AAA   427/427
(100 %)
0 diff
(100 %id)
CB321641 lung, Primary Lung Cystic Fibrosis EpithelialCells .d 2005 to 2430 440 to 15   AAA   426/427
(99 %)
2 diff
(99.6 %id)
BM671295 eye, optic nerve .d 2005 to 2430 444 to 19   AAA   426/428
(99 %)
0 diff
(100 %id)
CA432085 cell lines, Enchondroma .d 2005 to 2430 442 to 17   AAA   426/428
(99 %)
3 diff
(99.3 %id)
BU627019 Alveolar Macrophage, lung .d 2005 to 2430 442 to 17   AAA   426/426
(100 %)
0 diff
(100 %id)
BU609121 Human Lung Epithelial cells, lung .d 2007 to 2430 440 to 17   AAA   424/424
(100 %)
3 diff
(99.3 %id)
DB512354 testis .d 2011 to 2430 1 to 420     Submitted on the opposite strand 420/420
(100 %)
4 diff
(99.1 %id)
DB554178 hypothalamus .d 2012 to 2430 1 to 421     Submitted on the opposite strand 421/421
(100 %)
3 diff
(99.3 %id)
BM469774 melanotic melanoma, skin .d 2017 to 2430 1 to 415       415/1157
(35 %)
5 diff
(99.6 %id)
AI628330 serous papillary carcinoma, high grade, 2pooled tumors, uterus .d 2020 to 2431 412 to 1       412/412
(100 %)
0 diff
(100 %id)
AV741343 cord Blood .d 2022 to 2399 46 to 417       372/419
(88 %)
6 diff
(98.6 %id)
AA974149 pooled germ cell tumors .d 2033 to 2430 398 to 1       398/398
(100 %)
0 diff
(100 %id)
AA070148   .d 2041 to 2430 407 to 16   AAA   392/397
(98 %)
2 diff
(99.5 %id)
AI344683 2 pooled tumors (clear cell type), Kidney .d 2043 to 2430 399 to 12   AAA   388/388
(100 %)
2 diff
(99.5 %id)
AI814926 adenocarcinoma, Pancreas .d 2045 to 2432 388 to 1       388/388
(100 %)
0 diff
(100 %id)
AI348334 carcinoid, lung .d 2046 to 2430 385 to 1       385/385
(100 %)
0 diff
(100 %id)
AI569144 adenocarcinoma, Pancreas .d 2046 to 2432 390 to 4       387/390
(99 %)
0 diff
(100 %id)
AI191315 lung .d 2047 to 2432 393 to 8       386/393
(98 %)
0 diff
(100 %id)
AI571710 adenocarcinoma, Pancreas .d 2050 to 2430 399 to 19   AAA   381/381
(100 %)
1 diff
(99.8 %id)
AI262673 adenocarcinoma, colon .d 2052 to 2432 387 to 7       381/387
(98 %)
0 diff
(100 %id)
AI431676 adenocarcinoma, Pancreas .d 2055 to 2430 392 to 17   AAA   376/376
(100 %)
0 diff
(100 %id)
AI760988 B-cell, chronic lymphotic leukemia .d 2056 to 2432 378 to 2       377/378
(99 %)
0 diff
(100 %id)
AA830365 germinal center B cell .d 2057 to 2430 413 to 40   AAA   374/374
(100 %)
0 diff
(100 %id)
AA862551 pooled germ cell tumors .d 2057 to 2430 373 to 1       373/373
(100 %)
1 diff
(99.8 %id)
AA648952 germinal center B cell .d 2061 to 2430 413 to 45   AAA   369/369
(100 %)
1 diff
(99.8 %id)
BX383784   .d 2062 to 3004 954 to 11   tiling clone,   944/954
(98 %)
0 diff
(100 %id)
AA335016 epididymis .d 2067 to 2354 1 to 288       288/288
(100 %)
0 diff
(100 %id)
AI285174 adenocarcinoma, colon .d 2076 to 2430 388 to 34   AAA   355/361
(98 %)
17 diff
(95.3 %id)
AA773764 lung, lung carcinoma .d 2082 to 2428 347 to 1       347/347
(100 %)
0 diff
(100 %id)
AA973258 2 pooled tumors (clear cell type), Kidney .d 2083 to 2432 356 to 7       350/356
(98 %)
0 diff
(100 %id)
AI621335 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .d 2106 to 2430 325 to 1       325/325
(100 %)
0 diff
(100 %id)
F09139 brain, total brain .d 2135 to 2430 296 to 1       296/296
(100 %)
0 diff
(100 %id)
FN165067 breast carcinoma .d 2152 to 2249 106 to 7     Submitted on the opposite strand 100/106
(94 %)
0 diff
(100 %id)
FN173526 breast carcinoma .d 2167 to 2271 1 to 103       103/103
(100 %)
2 diff
(98.1 %id)
AA733048 heart .d 2200 to 2430 244 to 14   AAA   231/231
(100 %)
1 diff
(99.6 %id)
H08683 whole brain .d 2203 to 2429 254 to 28       227/254
(89 %)
0 diff
(100 %id)
FN140164 breast carcinoma .d 2207 to 2302 97 to 1     Submitted on the opposite strand 97/97
(100 %)
2 diff
(98.0 %id)
AA664854 alveolar rhabdomyosarcoma .d 2215 to 2432 220 to 3       218/227
(96 %)
0 diff
(100 %id)
AI335274 2 pooled tumors (clear cell type), Kidney .d 2217 to 2430 239 to 26   AAA   214/214
(100 %)
1 diff
(99.6 %id)
FN049712 breast carcinoma .d 2219 to 2275 1 to 56       56/57
(98 %)
2 diff
(96.5 %id)
F09141 brain, total brain .d 2225 to 2430 205 to 1       205/205
(100 %)
1 diff
(99.6 %id)
T63865 lung .d 2245 to 2402 159 to 1       159/159
(100 %)
3 diff
(98.2 %id)
C02597   .d 2278 to 2430 1 to 153       153/153
(100 %)
0 diff
(100 %id)
FN132987 breast carcinoma .d 2346 to 2436 1 to 89       89/97
(91 %)
3 diff
(97.0 %id)
BF794970 lymph, lymphoma, cell line .e 1 to 650 1 to 650   tiling clone,   650/650
(100 %)
1 diff
(99.9 %id)
BG749234 eye, normal pigmented retinal epithelium .e 15 to 923 1 to 908       908/929
(97 %)
26 diff
(97.3 %id)
BQ232466 embryonal carcinoma, cell line, testis .e 171 to 1012 1 to 846       846/850
(99 %)
10 diff
(98.9 %id)
BM463278 embryonal carcinoma, cell line, testis .e 174 to 1194 7 to 1033       1027/1033
(99 %)
27 diff
(97.4 %id)
BQ881833 brain, neuroblastoma, cell line .e 174 to 1087 23 to 936       914/936
(97 %)
14 diff
(98.6 %id)
TI_57231475   .e 174 to 1038 42 to 909       868/1123
(77 %)
13 diff
(98.9 %id)
BM806725 lymph, lymphoma, cell line .e 178 to 1077 1 to 911       911/1040
(87 %)
22 diff
(97.9 %id)
CR996446 T-Lymphocytes .e 246 to 1007 1 to 762       762/764
(99 %)
4 diff
(99.5 %id)
TI_154179436   .e 305 to 1172 76 to 940       865/866
(99 %)
18 diff
(98.0 %id)
TI_154179956   .e 305 to 1075 69 to 831       763/894
(85 %)
35 diff
(96.1 %id)
CA487363   .e 432 to 1210 1 to 791       791/1003
(78 %)
25 diff
(97.6 %id)
BQ231614 melanotic melanoma, skin .e 451 to 1210 1 to 762       762/873
(87 %)
5 diff
(99.5 %id)
BI824975 pooled brain, lung, testis .e 471 to 1193 30 to 753       724/857
(84 %)
13 diff
(98.5 %id)
TI_57196705   .e 471 to 1193 30 to 753       724/857
(84 %)
13 diff
(98.5 %id)
BG261018 bladder, transitional cell papilloma, cell line .e 517 to 1210 1 to 692       692/989
(69 %)
9 diff
(99.1 %id)
CD559056 White Matter .e 519 to 1210 18 to 712       695/961
(72 %)
10 diff
(99.0 %id)
BP351343   .e 565 to 1149 1 to 585       585/585
(100 %)
0 diff
(100 %id)
BE394353 endometrium, adenocarcinoma cell line, uterus .e 568 to 1207 1 to 639   tiling clone,   639/738
(86 %)
9 diff
(98.8 %id)
BF797221 lymph, lymphoma, cell line .e 596 to 1209 1 to 632       632/905
(69 %)
11 diff
(98.8 %id)
BI039434 nervous_tumor .e 598 to 1039 457 to 16       442/457
(96 %)
6 diff
(98.7 %id)
BE616010 adenocarcinoma, Pancreas .e 786 to 1145 1 to 360       360/362
(99 %)
2 diff
(99.5 %id)
AA356374   .e 833 to 1061 1 to 230       230/230
(100 %)
3 diff
(98.7 %id)
CA430241 cell lines, Chondrosarcoma .e 927 to 1634 726 to 19   tiling clone, AAA   708/708
(100 %)
2 diff
(99.8 %id)
BG230874 nasopharynx, normal epithelium .e 1384 to 1583 204 to 6       199/204
(97 %)
0 diff
(100 %id)
BG718957 testis .f 1 to 658 1 to 664 exact tiling clone,   660/664
(99 %)
14 diff
(97.9 %id)
BQ427867 melanotic melanoma, skin .f 405 to 1267 1 to 875   tiling clone,   875/888
(98 %)
6 diff
(99.4 %id)
BM471670 eye, retinoblastoma .f 890 to 1445 1 to 557   tiling clone, AAA   557/557
(100 %)
6 diff
(99.0 %id)
AA632346 breast .f 1036 to 1446 410 to 1       410/410
(100 %)
4 diff
(99.1 %id)
AA573259 breast .f 1122 to 1444 322 to 1       322/322
(100 %)
3 diff
(99.1 %id)
AI566316 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .f 1142 to 1447 310 to 5       306/310
(98 %)
0 diff
(100 %id)
CV399325 prostate_tumor .f 1290 to 1717 1 to 432   tiling clone,   432/432
(100 %)
8 diff
(98.2 %id)
BQ069430 brain, neuroblastoma, cell line .g 1 to 943 1 to 954 exact tiling clone,   954/1068
(89 %)
24 diff
(97.8 %id)
BG104601 adrenal cortex carcinoma, cell line, adrenal gland .h 1 to 757 1 to 760 exact tiling clone,   760/922
(82 %)
34 diff
(96.4 %id)
BM794168 Ascites, stomach .i-u 1 to 552 1 to 552 exact tiling clone,   552/552
(100 %)
0 diff
(100 %id)
CB269998 adipose .j-u 1 to 520 1 to 520 exact tiling clone,   520/521
(99 %)
3 diff
(99.5 %id)
AI015162   .k 1 to 326 326 to 1 E18G tiling clone,   326/326
(100 %)
2 diff
(99.4 %id)
AV705944 adrenal gland Gene C20orf4, variant not shown         Suspected internal deletion, this clone was ignored    
AV694559 hepatocellular carcinoma Gene C20orf4, variant not shown         Suspected internal deletion, this clone was ignored    
BE281459 choriocarcinoma, placenta Gene C20orf4, variant not shown         Suspected internal deletion, this clone was ignored    
BE747164 adenocarcinoma cell line, ovary Gene C20orf4, variant not shown         Suspected internal deletion, this clone was ignored    
BM559315 eye, retinoblastoma Gene C20orf4, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i-u, .j-u, .k Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI